FI115215B - Menetelmä oligonukleotidianalogien valmistamiseksi, joista on muodostettu 3'-johdannaisia ja joissa on ei-nukleotidisiä ryhmiä ja niiden käyttö - Google Patents

Menetelmä oligonukleotidianalogien valmistamiseksi, joista on muodostettu 3'-johdannaisia ja joissa on ei-nukleotidisiä ryhmiä ja niiden käyttö Download PDF

Info

Publication number
FI115215B
FI115215B FI930221A FI930221A FI115215B FI 115215 B FI115215 B FI 115215B FI 930221 A FI930221 A FI 930221A FI 930221 A FI930221 A FI 930221A FI 115215 B FI115215 B FI 115215B
Authority
FI
Finland
Prior art keywords
alkyl
formula
aryl
integer
group
Prior art date
Application number
FI930221A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI930221A (fi
FI930221A0 (fi
Inventor
Eugen Uhlmann
Gerard Joseph O'malley
Anuschirwan Peyman
Irvin Winkler
Matthias Helsberg
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI930221A0 publication Critical patent/FI930221A0/fi
Publication of FI930221A publication Critical patent/FI930221A/fi
Application granted granted Critical
Publication of FI115215B publication Critical patent/FI115215B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Graft Or Block Polymers (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
FI930221A 1992-01-22 1993-01-20 Menetelmä oligonukleotidianalogien valmistamiseksi, joista on muodostettu 3'-johdannaisia ja joissa on ei-nukleotidisiä ryhmiä ja niiden käyttö FI115215B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4201663 1992-01-22
DE4201663 1992-01-22

Publications (3)

Publication Number Publication Date
FI930221A0 FI930221A0 (fi) 1993-01-20
FI930221A FI930221A (fi) 1993-07-23
FI115215B true FI115215B (fi) 2005-03-31

Family

ID=6450031

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930221A FI115215B (fi) 1992-01-22 1993-01-20 Menetelmä oligonukleotidianalogien valmistamiseksi, joista on muodostettu 3'-johdannaisia ja joissa on ei-nukleotidisiä ryhmiä ja niiden käyttö

Country Status (18)

Country Link
US (1) US5646261A (ja)
EP (2) EP0552767B1 (ja)
JP (1) JP3676388B2 (ja)
KR (1) KR100273824B1 (ja)
AT (2) ATE307821T1 (ja)
AU (1) AU657191B2 (ja)
CA (1) CA2087817C (ja)
DE (2) DE59310287D1 (ja)
DK (2) DK1142902T3 (ja)
ES (2) ES2250268T3 (ja)
FI (1) FI115215B (ja)
HU (1) HUT63172A (ja)
IL (1) IL104460A (ja)
NO (1) NO308609B1 (ja)
NZ (1) NZ245721A (ja)
PL (1) PL172245B1 (ja)
PT (1) PT552767E (ja)
ZA (1) ZA93423B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2966849B2 (ja) * 1987-12-03 1999-10-25 三井化学株式会社 黄色系昇華転写用色材
DE59306170D1 (de) * 1992-09-24 1997-05-22 Hoechst Ag Oligoribonucleotid- und Ribozym-Analoga mit terminalen 3'-3'-bzw.5'-5'-Verknüpfungen
EP0602524A1 (de) * 1992-12-15 1994-06-22 Hoechst Aktiengesellschaft Chemilumineszenzmarkierte Gensonden und ihre Verwendung in Gensondentesten
CA2114355A1 (en) * 1993-01-29 1994-07-30 Hidehiko Furukawa Modified oligodeoxyribonucleotides, their preparation and their therapeutic use
US5532130A (en) * 1993-07-20 1996-07-02 Dyad Pharmaceutical Corporation Methods and compositions for sequence-specific hybridization of RNA by 2'-5' oligonucleotides
DE4408528A1 (de) * 1994-03-14 1995-09-28 Hoechst Ag Peptid-Oligonucleotid-Derivate, deren Herstellung und Verwendung
US6919441B2 (en) 1994-03-14 2005-07-19 Aventis Pharma Deutschland Gmbh Polyamide-oligonucleotide derivatives, their preparation and use
US6358689B1 (en) * 1994-05-11 2002-03-19 Boston University Detection of markers in nascent proteins
DE4418691A1 (de) * 1994-05-28 1996-02-22 Boehringer Mannheim Gmbh 3'-(4'-) nicht-radioaktiv markierte Nukleoside und Nukleotide mit Aminocarbonsäure-, Peptid- oder Carbonsäure-Spacer
WO1995032986A1 (en) * 1994-06-01 1995-12-07 Hybridon, Inc. Branched oligonucleotides as pathogen-inhibitory agents
US5696248A (en) * 1994-06-15 1997-12-09 Hoechst Aktiengesellschaft 3'-modified oligonucleotide derivatives
US6326487B1 (en) 1995-06-05 2001-12-04 Aventis Pharma Deutschland Gmbh 3 modified oligonucleotide derivatives
US6331617B1 (en) 1996-03-21 2001-12-18 University Of Iowa Research Foundation Positively charged oligonucleotides as regulators of gene expression
US6274313B1 (en) 1996-03-21 2001-08-14 Pioneer-Hybrid International, Inc. Oligonucleotides with cationic phosphoramidate internucleoside linkages and methods of use
US6121437A (en) 1999-03-16 2000-09-19 Isis Pharmaceuticals, Inc. Phosphate and thiophosphate protecting groups
US20040082774A1 (en) * 1999-03-16 2004-04-29 Guzaev Andrei P. Novel phosphate and thiophosphate protecting groups
US20040023367A1 (en) * 2002-07-31 2004-02-05 Affymetrix, Inc. Method of photolithographic production of polymer arrays
US8084589B2 (en) * 2007-08-31 2011-12-27 University Of Massachusetts Phosphoramidite nucleoside analogs
US20120082616A1 (en) * 2010-09-24 2012-04-05 Mallinckrodt Llc Aptamer Conjugates for Targeting of Therapeutic and/or Diagnostic Nanocarriers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3239888A1 (de) * 1982-10-28 1984-05-03 Hubert Prof. Dr. 2000 Hamburg Köster Verfahren zur herstellung von oligonucleosidphosphonaten
US4739044A (en) * 1985-06-13 1988-04-19 Amgen Method for derivitization of polynucleotides
DE3751468T2 (de) * 1986-10-30 1996-02-29 Daicel Chem Verfahren zur herstellung von oligonukleotiden und verbindungen zur bildung hochmolekularer schutzgruppen.
US4816571A (en) * 1987-06-04 1989-03-28 Applied Biosystems, Inc. Chemical capping by phosphitylation during oligonucleotide synthesis
US5216141A (en) * 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
US5399676A (en) * 1989-10-23 1995-03-21 Gilead Sciences Oligonucleotides with inverted polarity
EP0942000B1 (en) * 1989-10-24 2004-06-23 Isis Pharmaceuticals, Inc. 2'-Modified oligonucleotides
US5210015A (en) * 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
GB9021625D0 (en) * 1990-10-04 1990-11-21 Ici Plc Synthesis of oligonucleotides
FI115214B (fi) * 1992-01-22 2005-03-31 Hoechst Ag Menetelmä oligonukleotidianalogien valmistamiseksi ja niiden käyttö

Also Published As

Publication number Publication date
DK0552767T3 (da) 2002-08-19
ES2250268T3 (es) 2006-04-16
AU3191193A (en) 1993-07-29
HUT63172A (en) 1993-07-28
ES2177533T3 (es) 2002-12-16
DE59310287D1 (de) 2002-06-27
PT552767E (pt) 2002-10-31
IL104460A0 (en) 1993-05-13
PL297516A1 (en) 1993-09-06
FI930221A (fi) 1993-07-23
NO930200L (no) 1993-07-23
EP1142902A2 (de) 2001-10-10
DE59310380D1 (de) 2005-12-01
EP1142902A3 (de) 2001-10-17
HU9300161D0 (en) 1993-04-28
KR100273824B1 (ko) 2000-12-15
CA2087817C (en) 2010-03-16
NO308609B1 (no) 2000-10-02
EP0552767B1 (de) 2002-05-22
ATE217881T1 (de) 2002-06-15
CA2087817A1 (en) 1993-07-23
ATE307821T1 (de) 2005-11-15
NZ245721A (en) 1995-09-26
EP1142902B1 (de) 2005-10-26
EP0552767A2 (de) 1993-07-28
FI930221A0 (fi) 1993-01-20
JP3676388B2 (ja) 2005-07-27
KR930016438A (ko) 1993-08-26
PL172245B1 (pl) 1997-08-29
AU657191B2 (en) 1995-03-02
JPH05310778A (ja) 1993-11-22
NO930200D0 (no) 1993-01-21
DK1142902T3 (da) 2006-03-06
EP0552767A3 (en) 1994-09-07
ZA93423B (en) 1993-09-09
IL104460A (en) 2003-03-12
US5646261A (en) 1997-07-08

Similar Documents

Publication Publication Date Title
FI115214B (fi) Menetelmä oligonukleotidianalogien valmistamiseksi ja niiden käyttö
FI115215B (fi) Menetelmä oligonukleotidianalogien valmistamiseksi, joista on muodostettu 3'-johdannaisia ja joissa on ei-nukleotidisiä ryhmiä ja niiden käyttö
US5955599A (en) Process for making oligonucleotides containing o- and s- methylphosphotriester internucleoside linkages
US5596091A (en) Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides
EP0506242B1 (en) Method and compounds for solid phase synthesis of oligonucleotides and oligonucleotide analogs
US6140482A (en) Primary phosphoramidate internucleoside linkages and oligonucleotides containing the same
JP3186795B2 (ja) 末端３′−３′または５′−５′ヌクレオチド間結合を有するオリゴヌクレオチド類似体
JP3831407B2 (ja) メチルホスホン酸エステル、その製造方法およびその使用
CA2151801C (en) 3'-modified oligonucleotide derivatives
JP4620810B2 (ja) ポリアミド−オリゴヌクレオチド誘導体、その製造及び使用
JP3653102B2 (ja) 末端３′−３′および／または５′−５′連鎖を有するオリゴリボヌクレオチドおよびリボザイム類縁体
US6033909A (en) Oligonucleotide analogs, their preparation and use
US5571937A (en) Complementary DNA and toxins
RU2111971C1 (ru) Модифицированные олигодезоксирибонуклеотиды, композиция на их основе и промежуточные соединения
WO1996039414A1 (en) Novel base protecting groups for oligonucleotide synthesis
US6509459B1 (en) Base protecting groups and rapid process for oligonucleotide synthesis
WO1998033806A1 (en) Base protecting groups and process for oligonucleotide synthesis
WO1998005675A2 (en) Radiolabeled o-methyl phosphotriester and o-methyl phosphorothioate internucleoside linkages and oligonucleotides containing the same
CA2122470A1 (en) Oligonucleotides having aminohydrocarbon phosphonate moieties
WO1998021226A1 (fr) Derive oligonucleotidique h-phosphonate et procede de production associe

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 115215

Country of ref document: FI

MA Patent expired